Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;6(1):e001084.
doi: 10.1136/rmdopen-2019-001084.

Management of Fatigue in Rheumatoid Arthritis

Affiliations
Review

Management of Fatigue in Rheumatoid Arthritis

Janet E Pope. RMD Open. 2020 May.

Abstract

Fatigue in rheumatoid arthritis is highly prevalent. It is correlated only weakly with disease activity but more so with pain, mood, personality features, poor sleep, obesity and comorbidities. Fatigue can be measured by many standardised questionnaires and more easily with a Visual Analogue Scale or numeric rating scale. Most patients with RA have some fatigue, and at least one in six have severe fatigue. Chronic pain and depressed mood are also common in RA patients with significant fatigue. It affects function and quality of life and is worse on average in women. Evidence-based treatment for fatigue includes treatment of underlying disease activity (with on average modest improvement of fatigue), exercise programmes and supervised self-management programmes with cognitive-behavioural therapy, mindfulness and reinforcement (such as reminders). The specific programmes for exercise and behavioural interventions are not standardised. Some medications cause fatigue such as methotrexate. More research is needed to understand fatigue and how to treat this common complex symptom in RA that can be the worst symptom for some patients.

Keywords: Ant-CCP; Rheumatoid Arthritis; Systemic Lupus Erythematosus; Systemic Sclerosis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: AbbVie, Actelion, Amgen, Bayer, BMS, Emerald, Genzyme, Janssen, Lilly, Merck, Novartis, Pfizer, Roche, Sandoz, Sanofi, UCB; RCTs: Bayer, BMS, Merck, Roche, Seattle Genetics, UCB.

Figures

Figure 1
Figure 1
Framework of fatigue in rheumatoid arthritis (RA).

References

    1. Taylor PC, Moore A, Vasilescu R, et al. . A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective. Rheumatol Int 2016;36:685–95.10.1007/s00296-015-3415-x - DOI - PMC - PubMed
    1. Pollard LC, Choy HE, Gonzalez J, et al. . Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology. 2006;45:885–9.10.1093/rheumatology/kel021 - DOI - PubMed
    1. Hewlett S., Cockshott Z., Byron M., Kitchen K., Tipler S., Pope D., Hehir M., et al. . Patients’ perception of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum 2005;53:697–702.10.1002/art.21450 - DOI - PubMed
    1. Nikolaus S, Bode C, Taal E, et al. . Fatigue and factors relating to fatigue in rheumatoid arthritis: a systematic review. Am Coll Rheumatol 2013;65:1128–46. - PubMed
    1. Zielinski MR, Systrom DM, Rose NR, Fatigue, sleep, and autoimmune and related disorders. Front Immunol 2019;10:1827.10.3389/fimmu.2019.01827 - DOI - PMC - PubMed